An Evaluation of Clinical Practices among UK General Practitioners in Managing Individuals Attempting to Quit Smoking with Varenicline

Sep-15

General Analysis Pharmacoepidemiology Smoking

AUTHORS : Muhammad Younus, Epidemiology, Worldwide Safety and Strategy, Pfizer Inc, New York, New York, USA – Email: : muhammad.younus2@pfizer.com

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 24(S1):471-472

DOI : 10.1002/pds.3838

An Evaluation of Clinical Practices among UK General Practitioners in Managing Individuals Attempting to Quit Smoking with Varenicline

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study